Filing Details

Accession Number:
0001179110-14-017250
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-01 12:07:35
Reporting Period:
2014-11-28
Filing Date:
2014-12-01
Accepted Time:
2014-12-01 12:07:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1294682 M Bennett Shapiro C/O Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-11-28 1,897 $12.00 10,834 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-11-28 1,897 $10.44 1,897 $10.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
159,303 2006-05-26 2015-05-26 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on May 12, 2014.